








Sigrid Vertommen1 , Vincenzo Pavone2
and Michal Nahman3
Abstract
Over the last two decades, social scientists across disciplines have been
researching how value is extracted and governed in the reproductive
bioeconomy, which broadly refers to the various ways reproductive tissues,
bodies, services, customers, workers, and data are inserted into capitalist
modes of accumulation. While many of these studies are empirically
grounded in single country–based analyses, this paper proposes an inte-
grative political economy framework, structured around the concept of
“global fertility chains.” The latter articulates the reproductive bioeconomy
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as a nexus of intraconnected practices, operations, and transactions
between enterprises, states, and households across the globe, through
which reproductive services and commodities are produced, distributed,
and consumed. Employing a diffractive reading of the literature on com-
modity chains and care chains, this unified approach scrutinizes the
coproduction of value, biology, and technoscience and their governance
mechanisms in the accumulation of capital by taking into account (1) the
unevenly developed geographies of global fertility chains, (2) their reliance
on women’s waged and unwaged reproductive labor, and (3) the networked
role of multiple actors at multiple scales without losing sight of the (4)
constitutive role of (supra)national states in creating demand, organizing
supply, and accommodating the distribution of surplus value. We empiri-
cally ground this integrative political economy approach of the reproductive
bioeconomy through collaborative, multisited fieldwork on transnational
reproduction networks in Israel/Palestine, Romania, Georgia, and Spain.
Keywords
bioeconomy, political economy, reproductive labor, the state, uneven
development, value chains, governance, assisted reproduction
Introduction
Tammuz Family is Israel’s first fertility agency with a specialization in
surrogacy for same-sex couples. When its director was asked about the
business model behind his company in 2014, he explained: “Basically, I
united sperm from gay Israelis with eggs from donors in the USA or other
Western nations, couriered the fertilized eggs to a clinic near Mumbai and
implanted them in the wombs of Indian surrogate mothers.”1 When the
Indian government prohibited surrogacy for foreign couples in 2016, how-
ever, Tammuz decided to change its business strategy and fly the Indian
surrogates to neighboring Nepal. Here, Tammuz established its own fertility
clinic in Kathmandu, integrating the medical and logistical services along
the global surrogacy chain. As the director of Tammuz clarified in 2017:
“We want to offer a one-stop-shop for surrogacy services, helping intended
parents through all aspects of the surrogacy journey.”
This ethnographic snapshot, taken from Vertommen’s research on trans-
national surrogacy, illustrates how the introduction of in vitro fertilization
(IVF) in the late 1970s has paved the way for the (re)development of a
reproductive bioeconomy, crystallized around the global fragmentation and
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flow of reproductive tissues, bodies, technologies (ART), services, workers,
and consumers (Inhorn 2011; Weinbaum 2019).2 According to recent stud-
ies, the global fertility market is estimated to become a US$40 billion
market by 2026 (Databridge Market Research 2019). In the United States,
the fertility power par excellence, the market for in/fertility services and
technologies is expected to grow from approximately US$6 billion in 2019
to US$8 billion in 2023. In China, revenues are likely to double to over
US$7 billion by 2023 (Frost and Sullivan 2019). In Spain, it has been
calculated that the IVF industry generated around €550 million in 2013
alone (López Gálvez and Moreno Garcı́a 2015).
In its broadest sense, the reproductive bioeconomy refers to the ways
reproductive tissues, services, customers, workers, and data come to be part
of ongoing capitalist modes of accumulation. Over the last two decades,
social scientists across disciplines have researched how the reproductive
bioeconomy operates, foregrounding the importance of sociotechnological
innovations in the reproductive bioeconomy (Franklin and Lock 2003;
Rajan 2006; Helmreich 2008; Pavone and Goven 2017). Others, however,
have wondered whether there is something unique about the bioeconomy
and suggest reframing theories of biological productivity through theories
of rent and assets under neoliberal capitalism (Birch and Tyfield 2013;
Birch 2019). Meanwhile, feminist scholars have emphasized the gendered
exploitation of reproductive or clinical labor, from the perspectives of the
primary sources of value extraction: surrogates and tissue donors (Nah-
man 2008, 2013; Pande 2010; Cooper and Waldby 2014; Lewis 2019).
Notwithstanding some exceptions (Knecht, Beck, and Klotz 2012; Nah-
man 2013; Inhorn 2015), most empirical research on the reproductive
bioeconomy resulted from single country–based analyses of the fertility
or health-care industry in India (Rudrappa 2015; Pande 2014; Deomampo
2016), Mexico (Schurr 2017), Spain (Pavone and Arias 2012; Marre,
Román, and Guerra 2018), Israel/Palestine (Teman 2010; Birenbaum-
Carmeli and Carmeli 2010; Vertommen 2016, 2017), South Africa (Pande
and Moll 2018; Namberger 2019), and the United States (Spar 2006;
Smietana 2017). While all these studies undoubtedly introduce significant
approaches to understanding how value is extracted, captured, and gov-
erned within the reproductive bioeconomy, what remains is to develop a
coherent conceptualization and operationalization of how these unique
national reproductive markets link together in the world economy and
with what effects.
This article proposes an integrative political economy approach to the
reproductive bioeconomy based on multisited qualitative fieldwork,
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centered on the concept of “global fertility chains.” It articulates the repro-
ductive bioeconomy as a nexus of intraconnected practices, operations, and
transactions among the enterprises, states, and households through which
reproductive services and commodities are produced, distributed, and con-
sumed across the globe in the accumulation of capital. This unified
approach demands an understanding of the interdependence of four impor-
tant dimensions: (1) the global, yet unevenly developed, geographies of
fertility chains, (2) the reliance on biology/labor networks and women’s
waged and unwaged reproductive labor, and (3) a networked input–output
structure comprising multiple actors at multiple scales, without losing sight
of the (4) constitutive governance role of (supra)national states in creating
demand, organizing supply, and accommodating the creation and distribu-
tion of surplus value. We will unpack this integrative conceptualization of
value extraction and governance in the reproductive bioeconomy by explor-
ing examples of existing global fertility chains from our respective field-
work on transnational reproduction networks in Israel, Romania, Georgia,
and Spain.
Over the past two decades, these countries have been directly and indir-
ectly connected via emerging fertility chains in commercial surrogacy and
egg cell provision. Since the early 2000s, a vibrant transnational fertility
industry has developed in Israel that serves the reproductive needs of infer-
tile and dysfertile couples who wish to have a biologically related child.
Romania was one of the first countries where cheap and available egg cell
providers were recruited in Israeli proxy clinics. Surrogates were first con-
tracted in South East Asian countries, but after Thailand, India, Nepal, and
Cambodia recently tightened their surrogacy regulations, Georgia emerged
as one of the preferred surrogacy destinations for Israeli couples. Spain has
become the egg donation hub in Europe: more than half of the egg donation
cycles in Europe are performed in Spain, and more than 20 percent of the
overall IVF cycles are catered to foreign recipients, who travel to Spain,
mostly from Italy, Germany, United Kingdom, and France, to access egg
donation and, to a lesser extent, IVF with preimplantation diagnosis.
Finally, Spain is home to a number of intermediaries that offer support and
guidance throughout the process of surrogacy to couples who are set to
access this treatment abroad, as the latter is not currently allowed in Spain.
Sigrid Vertommen conducted qualitative research on international sur-
rogacy in Israel/Palestine and Georgia based on more than sixty semistruc-
tured interviews with surrogates, egg cell providers, and surrogacy agents of
fertility doctors, government officials, and lawyers in both Israel (2012-
2019) and Georgia (2018). Vincenzo Pavone and his research assistant
4 Science, Technology, & Human Values XX(X)
conducted qualitative research on the (globalized) egg cell markets in Spain
(2013-2015) based on twenty semistructured interviews with medical prac-
titioners, embryologists, gynecologists, egg bank coordinators, and market-
ing directors in ten private and one public hospital in five different regions
across the country. Michal Nahman conducted research on cross-border egg
donation in Israel/Palestine and Romania (2002-2010), including interviews
with fifty recipients of reproductive services; ethnographic research in three
Israeli and Romanian egg donation clinics, involving hours of observation
of clinical practice of oocyte extraction, fertilization, and implantation;
interviews with recruiters and clinicians across the process; and interviews
with twenty-one Romanian egg providers in 2002. She also conducted
research with a focus on repro-migrations in two Spanish clinics in
Barcelona, including seventeen interviews with migrant egg providers and
additional interviews with clinicians in Barcelona, Spain (2016-2018). This
paper draws on data from different time periods, as it is a collaboration
among three authors who have done their research independently over the
course of eighteen years. The theoretical intervention we are making here
comes from several years of collaborative thinking around these topics.
This is also one of the methodological arguments we make in this paper:
More qualitative research on the reproductive bioeconomy should be done
collaboratively and simultaneously along the fertility chain by multiple
(teams of) researchers.
Drawing insights from distinctive yet interconnected fieldwork sites, the
article will first take a closer look at the existing research on the political
economy of the reproductive bioeconomy before proposing the alternative
framework of global fertility chains and its different components as iden-
tified above.
The Reproductive Bioeconomy: State of the ART
Over the past two decades, researchers in anthropology, medical sociology,
political economy, and science and technology studies have theorized the
emergence of reproductive bioeconomies. These are broadly defined as
biocapitalist projects of accumulation structured around the commodifica-
tion and assetization of reproductive tissues, data, organs, and services for
the production of babies or innovative medical technologies (Strathern
1992; Helmreich 2008; Cooper and Waldby 2014; Pavone and Goven
2017; Hogarth 2017; Geiger and Nicole, 2021).
From an science and technology studies (STS) perspective, scholars have
pointed out how technologies, legal regulations, societal practices, and
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economic priorities are arranged into complex and articulated value chains
in which biomaterials like gametes and embryos get transformed into bio-
objects that can be standardized, accessed, possessed, valued, and traded
across the world (Vermeulen, Tamminen, and Webster 2016). Many
“bioconcepts” (Birch and Tyfield 2013) have been introduced, ranging from
biovalue (Waldby 2002), biocapital (Franklin and Lock 2003; Rajan 2006),
bioeconomics (Rose 2007), and biomedical mode of reproduction
(Thompson 2005) to life as surplus (Cooper 2008) in order to make sense
of what is perceived as a new phase in contemporary capitalism that feeds
on the extraction of surplus vitality from biological tissues and the commo-
dification of biological processes.
Other STS scholars who look at more speculative domains associated
with regenerative medicine, experimental biotechnology, and genetic
engineering have fundamentally critiqued these theories of biocapital and
the bioeconomy for their technoscientific focus on the presumed novelty
of the relation between biotechnology and capitalism without paying
much attention to neoliberal processes of financialization (Lave, Mir-
owski, and Randalls 2010; Birch and Tyfield 2013; Goven and Pavone
2015; Birch 2019). Birch and Tyfield (2013), for instance, have proble-
matized the STS “fetishization of biological matter” that assigns agential
power to biological tissues such as oocytes, stem cells, and placentas.
Following Marx’s labor theory of value, they posit that value is realized
not only through the embodied labor power of workers but also and espe-
cially through how knowledge is applied to nature rather than through any
pregiven characteristic of biological matters. As they state: “Value results
from the application of knowledge to nature, and the subjection of that
knowledge to intellectual property rights, and not from nature itself or
from particular biological material (p. 221). In this vision, it is the ability
to restrict access to knowledge and inventions that allows patents, intel-
lectual property, monopolies, and immaterial assets in general to generate
a flow of income (Zeller 2008; Birch 2019). While oocytes and wombs
themselves might not have agency, the providers of those reproductive
tissues, organs, and materials clearly do.
However, feminist scholars suggest that women workers and their repro-
ductive biologies, bodies, and labor power tend to “vanish” in political
economy debates around bioeconomies (Dickenson 2007; Nahman 2008).
With a focus on assisted reproduction, these scholars have conceptualized
the reproductive bioeconomy as a deeply technological capitalist project
that incorporates the preexisting processes of exploitation of women’s
reproductive bodies, services, and work. Bringing the labor of biological
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reproduction into the debates on social reproduction under capitalism, they
have proposed concepts such as reproductive labor (power; Dickenson
2007; Pande 2014; Rudrappa 2015; Namberger 2019; Newman and
Nahman 2020; Vertommen and Barbagallo 2021), gestational labor (Vora
2015; Lewis 2019), or clinical/regenerative labor (Cooper and Waldby
2014) to understand women’s indispensable role within the reproductive
bioeconomy. By framing surrogacy, egg cell provision, or tissue donations
as labor that is precarious, un(der)valued, and unrecognized, this perspec-
tive looks at the gendered nature of value creation and labor within capi-
talist economies.
These studies have cast important light on the actual novelties of emer-
ging bioeconomies, on their abilities to reframe social problems into tech-
nological issues, on their undergirding labor and property regimes, and on
the discriminating and disempowering practices that these economies pro-
mote (Helmreich 2008; Pavone and Goven 2017). What is still often miss-
ing, however, is an integrative political economy framework that interlinks
the analytical and political concerns on seemingly national reproductive
bioeconomies with global processes of capital accumulation (Franklin
2011; Birch 2012; Lafuente-Funes 2020). While a political economy frame-
work on the reproductive bioeconomy can motivate a broad set of research
questions and agendas (including innovation models and dynamics, orga-
nization of fertility markets, processes of financialization and datafication,
labor, property regimes, etc.), this paper proposes the concept of “global
fertility chains” as a way both to theorize and to empirically map the global
reorganization of reproductive processes as coproduced by the changing
relations—or “intra-actions”—among capital, labor, nature/biology, tech-
noscience, and their governance mechanisms (Barad 2007).
Global Fertility Chains: A New Political Economy of
the Reproductive Bioeconomy
Drawing on the literature on global commodity/value chains (Hopkins and
Wallerstein 1986; Gereffi and Korzeniewicz 1994; Bair 2005, 2008;
Dunaway 2014; Mezzadri 2017) and production networks (Coe, Dicken,
and Hess 2008; Kelly 2009; Rainnie, Herod, and Mcgrath-Champ 2011), on
the one hand, and on global care chains, on the other hand (Salazar Parreñas
2001; Ehrenreich and Hochschild 2002; Yeates 2004), we propose a new
political economy perspective to analyze the reproductive bioeconomy,
centered on the concept of global fertility chains.3
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While more recent explorations of the political economy of the biotech-
nology and/or reproductive industry have advanced a technoassemblage
framework (Ong and Collier 2010; Knecht, Beck, and Klotz 2012; Müller
and Schurr 2016), we argue that the chain or network approach offers
valuable analytical, methodological, and political tools to understand both
the contingent and structural complexities of value extraction and govern-
ance in the global bioeconomy (Castree 2002; L. D. A. Williams 2017).
Originating from world-systems theory, Hopkins and Wallerstein (1986,
159) defined commodity chains as “networks of labor and production pro-
cesses whose end result is a finished commodity.” They argued that each
step or node in the production process involves inputs, labor power, trans-
portation, distribution, and/or consumption (Gereffi and Korzeniewicz
1994, 2). Although commodity chains are (often) transnational networks
of economic organization, it is understood that they are locally integrated
and thus socially embedded in a particular time and place (Bair 2005; Coe,
Dicken, and Hess 2008).
From a perspective rooted in feminist and sociology literature on migrant
labor, the concept of global care chains looks at “the personal links between
people across the globe based on the paid or unpaid work of caring” (Hochs-
child 2000, 131; Salazar Parreñas 2001). Rather than focusing strictly on
how surplus value is captured in the global production of commodities, they
foregrounded the modes of reproduction and linkages between capitalist
accumulation and the mobility of reproductive labor(ers) in care chains of
nannies, domestic workers, and nurses (Yeates 2004, 2009). Although fem-
inist scholars have raised important caveats in using the “productivist”
framework of commodity chains to analyze reproductive or care industries
(Murphy 2014), this approach offers a useful perspective to analyze the
dynamic, structural, and relational nature of how reproductive services and
commodities are produced, distributed, and consumed (Yeates 2009).
Focusing on global fertility and cross-border reproductive care, Inhorn
(2015, 22, 25) describes reproscapes and reproflows, as dynamic assem-
blages of “technologies invented in one country, which then flow to others
through a variety of commercial means,” as “embryos flowing from one
country to another through the work of embryo couriers carrying their
cryopreservation tanks,” and as “men and women flowing across transna-
tional borders in search of reproductive assistance or as reproductive assis-
ters who flow or are flown to other countries in transnational reproductive
networks.”
Building on these insights, we define fertility chains as a nexus of intra-
connected practices, operations, and transactions among firms, states, and
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households through which a particular reproductive service (such as egg
provision or surrogacy), commodity (such as a baby, stem cell line, regen-
erative drug, or therapy) or data are produced, distributed, and consumed
across the globe. The analytical aims of the global fertility chain framework
are twofold. First, to map the fertility chain and identify the geography and
activities of actors involved in the reproductive bioeconomy. Second, to
analyze the value chain and determine the role that dynamic factors (labor/
biology networks, institutional governance, technological innovations,
colonial histories, and interfirm relationships) play in shaping the develop-
ment and profitability of fertility services (Frederick 2016).
What is the added value of introducing this global reproduction network
framework? Contrary to classic political economy and value chain analysis
that tend to focus on commodity production, market dynamics, and inter-
firm transactions, a global fertility chain analysis foregrounds highly gen-
dered and racialized dynamics that are usually left out, taken for granted, or
viewed as external factors in value chain analysis (Moore 2015). For
instance, the regulatory role of states and other governance institutions and
the appropriation of what Mies (1982, 2014) has termed the “free” gifts of
nature/biology, women, and colonized peoples. An “integrative” political
economy perspective of the bioeconomy means an insistence on the copro-
duction of capital, nature/biology, and technoscience in the (re)production
of babies and medical technologies (Jasanoff 2004). Operationalizing this
integrative framework in a way that motivates multisited empirical analysis,
we foreground four key analytical components. Global fertility chains con-
sist of (1) multiple sociotechnical actors that are transnationally connected,
in which (2) the (supra)national state plays a constitutive governance role in
creating the demand, organizing the supply, and accommodating the cre-
ation of surplus value. These chains are (3) heavily dependent on women’s
waged and unwaged reproductive labor and (4) structured by geographies of
uneven development. We will further unpack these four features in the
following empirical section.
Sociotechnical Nexus of Multiple Actors and Scales
One of the strengths of a chain epistemology is that it offers a decentered
understanding of how value is captured and added in the world economy by
incorporating multiple actors and scales in the analysis (Kelly 2009). Ferti-
lity chains often transcend state borders and connect actors in different
localities, countries, and continents. They incorporate a wide spectrum of
sociotechnical actors: fertility agencies and brokers; fertility clinics and
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hospitals; pharmaceutical and biotechnology companies; start-ups; surro-
gates; egg providers; reproductive technologies; medicine; therapies;
embryos; sperm and egg cells; medical staff including doctors, embryolo-
gists, nurses, and genetic counselors; law firms specialized in family law
and migration; shipping and logistics companies; scientists; patent offices;
technology transfer companies; venture capital firms; feminist and lesbian,
gay, bisexual, and transgender organizations; national ministries of health;
foreign affairs and justice; intending parents; national embassies; social
media groups; patient organizations; nannies; drivers and households; and
so on. In this sense, fertility chains complicate the traditional focus of
commodity/value chain analysis on the firm and the transnational company
as the driving epicenters of value creation (Rainnie et al. 2011). It includes a
broad array of human and extrahuman, productive and reproductive, waged
and unwaged actors who contribute to making babies, medical therapies,
and wealth. But rather than tending toward contingency and usually hor-
izontal (or even flat) ontologies (as would be discerned through an assem-
blage or even actor–network theory approach), fertility chains entail
structural power hierarchies among different actors of any network. Those
hierarchies are viewed as central, and the global fertility chains model is
intent on identifying systematic logics or “general processes of socionature”
(Castree 2002, 134) in current modes of (bio)capitalist accumulation.
Examining the global fertility chain between Israel and Georgia, Ver-
tommen, for instance, maps the different actors by following the reproduc-
tive trail of Israeli-intended parents who wish to conceive a baby through
transnational commercial surrogacy. She describes how in Israel’s prona-
talist climate, infertile and dysfertile couples are increasingly contracting
surrogacy agencies to make their dreams of genetic parenthood come true.
Since Tammuz Surrogacy was founded in 2008, dozens of other surrogacy
agencies have surfaced in the Tel Aviv area. These private companies
broker the reproductive demands of the intended parents and the availability
of overseas egg vendors and surrogate carriers. They also coordinate all the
fertility procedures that need to be completed in Israel (IVF, egg retrieval,
sperm donation, etc.) and follow up on the legal issues to officialize and
regulate the parent–child relationship and the citizenship status of the baby.
Although commercial surrogacy is allowed in Israel, its complex bureau-
cracy and high cost opened the door for a successful transnational surrogacy
industry (Eyal and Moreno 2018). After Thailand, India, Nepal, Cambodia,
Laos, and Mexico tightened their surrogacy legislation, Israeli surrogacy
agencies discovered Georgia, the perfect new “mother” destination, easily
reachable via a short direct flight, and having permissive surrogacy
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legislation, a deregulated economic architecture, and a low-cost reproduc-
tive labor force.
In Georgia, Israeli surrogacy agencies cooperate with a local fertility
agency and with a medical clinic. Some Israeli surrogacy brokers contract
professional couriers to ship the frozen sperm, egg cells, or embryos to their
Georgian counterpart, while others save costs by personally delivering the
reproductive materials, transported in carry-on cryopreservation tanks on a
regular passenger flight (a practice initiated by Israeli doctors who began
the transnational transport of fertilized embryos between Romania and
Israel in the early 2000s). The Georgian surrogacy agencies recruit the
surrogates and egg vendors through social media or with the help of former
surrogates who act as intermediaries, match them with the commissioning
parents, and follow up on their medical appointments in the clinics. They
also coordinate care and logistics for Israeli commissioning parents, once
they arrive in Georgia to pick up their surrogacy babies. This might include
arranging accommodation, food, and transportation for the parents and
nannies, nurses, and breast milk for the baby. To ensure the smooth “return”
of the surrogacy babies to Israel, Georgian agencies need to coordinate with
lawyers, notary bureaus, and national embassies to arrange the citizenship
status and travel documents of the newly born. Müller and Schurr (2016)
and Schurr (2018) argue that the main challenge for surrogacy companies is
to create stability amid highly volatile global networks that can easily shift
depending on changes in national legislation. For surrogacy companies
worldwide, the main business strategy in dealing with the contingent spa-
tiotemporality of global fertility chains has been to circumvent national
legislations at the surrogacy frontier (Bergmann 2011).4 Despite the chal-
lenges inherent in adapting fertility services to new contexts, Schurr (2018,
4) posits that this legal volatility is also part of the profitability of surrogacy
agencies globally, as “they have a rather immutable, standardized, and
uniform business system in which they circulate the very same templates,
contracts, and manuals to their branches in different regions of the world.”
The Georgian clinics and hospitals are private medical facilities that
specialize in fertility treatments. They perform all the medical screenings
and treatments for the surrogates and egg providers. When asking one
fertility doctor in Tbilisi in 2018 why there are so few governmental reg-
ulations and legal restrictions for fertility clinics, she replied: “I don’t know,
but I know that we are in heaven. I can do everything.” The Georgian clinics
operate in a highly deregulated economic landscape in which health-care
facilities are increasingly privatized and controlled by financial institutions
such as the Bank of Georgia and its health-care subsidiary Evex.5 last entry
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February 22, 2019). This follows a growing trend of financialization and
consolidation in the global fertility market in which large-scale financial,
medical, and biotechnology companies are incorporating IVF clinics
around the world as local subsidiaries (van de Wiel 2018). In the next
section, we switch our attention to another crucial actor in the transnational
surrogacy chain, that is, the reproductive labor force, consisting of surrogate
carriers and egg providers.
Women’s Waged and Unwaged Reproductive Labor
In her research on migrant reproductive workers, Truong (1996, 47) argued
that “no production system can operate without a reproduction system.”
However, the reproductive realm is often overlooked or minimized in com-
modity/value chain analysis and in political economy scholarship in gen-
eral.6 A global fertility chains approach offers a feminist political economy
lens through which to address the gendered and racialized division of labor
in capitalist economic processes by putting the quintessential role of
women’s laboring bodies center stage. It revisits how value is extracted
and distributed in commodity circuits, furthering the social reproduction of
labor and capital (Bair 2010; Yeates 2009; Dunaway 2014; Mezzadri 2017).
Indeed, global fertility chains are highly dependent on the appropriation and
exploitation of women’s unpaid and paid reproductive labor. However, the
sexual division of labor structuring global fertility chains renders the
spheres of production and reproduction ontologically separate. The former
sphere seemingly produces economic value while the latter “merely” repro-
duces life (Mies 2014). Recent scholarship argues that it is through these
seemingly natural dualisms of production versus reproduction, nature ver-
sus society, gift versus commodity, and waged versus unwaged work that
fertility industries become viable and lucrative enterprises (Pande 2014;
Moore 2015; Waldby and Mitchell 2006; Cooper and Waldby 2014; Parry
2018; Newman and Nahman 2020; Vertommen and Barbagallo 2021).
The sexual division of labor in the bioeconomy is usually characterized
by a Cartesian mind–body split, in which only the cognitive labor of the
scientist or doctor is valorized while the reproductive labor of (female)
oocyte vendors and surrogates is made invisible and presented as natural
(Waldby and Mitchell 2006; Cooper and Waldby 2014). Under capitalist
modes of accumulation, processes of ovulation, gestation, and parturition
are not valued as labor, neither in their unpaid form as motherhood and
“natural” pregnancy nor in their commodified form as commercial surro-
gacy or egg cell provision. In the surrogacy and egg-providing industries we
12 Science, Technology, & Human Values XX(X)
have researched, where reproductive labor is one of the obvious sources of
profit, we witnessed how fertility brokers still use the language of donation,
gift-giving, or altruism to promote their services (Ragone 1994; Vertommen
and Barbagallo 2021).
Yet for the women providing the oocytes, it is somewhat more ambiva-
lent. In research into migrant women providing eggs in Spain, Nahman
questioned women as to whether they viewed it as “work.” Ieva, a Latvian
two-time oocyte provider interviewed in 2016 and 2017, stated:
“So maybe for somebody it (donation) is good. For somebody who doesn’t
have work. Me for example, I am not considering doing that many times. It is
not my job. I—my job is different. I prefer . . . Yeah. well. I prefer to work.
Before, if you want work, you could always get a job. Maybe not so many
hours, or days. But you could do it. But is [egg providing] like a job? No. You
can do it (more often) maybe after you have children ( . . . ).”
For Ieva, egg donation was good to do if you do not have paid employ-
ment. But she made the clear distinction between egg providing and a “job,”
saying “it’s not my job,” and that she prefers to work in traditional forms of
employment. Indicating that she does not see providing eggs as labor.
Meanwhile, Leah, a German seven-time egg provider in Spain who told
the interviewer she provided eggs as a “summer job,” stated that she does it
precisely for the money:
I asked (to donate) because now that I need the money in the summer—it is
nice—the extra. ( . . . ) It is always a nice extra budget. An easily earned
money, so to say.
Contrary to Ieva, Leah likened egg providing to work. In research based
in Romania in 2002, Nahman found that egg providers viewed themselves
as “selling.” One might question what they are selling, whether it is their
labor power, or the egg, or the end product of a baby? The ambivalence of
egg providers as to whether it is a job or not belies the fact that they are
central to the appropriation of value. Meanwhile, in a process that Mies
(1982) would term “housewifization,” they are schooled to believe their
bodies “naturally” produce babies and eggs and therefore this is not seen by
them or the brokers as the source of value creation.7
There was also ambiguity in how the brokers or recipients viewed the
egg provider, whether as laborer or donor, and this ambiguity is what
supports classifying her provision of the product (baby/egg) as part of
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“nature” and not part of the market. In her research on the transnational
oocyte industry between Israel and Romania, Nahman (2013) introduced
the concept of “extraction” to describe how the fertility industry appropri-
ates surplus value from women’s bodies, from their (racialized) egg cells,
embryos, wombs, umbilical cords, fetal tissues in what, similar to mining or
fracking, can be called an extractive industry. This form of extraction relied
on the unevenly developed geographies (a central feature of how we
conceptualize global fertility chains (GFC), discussed further in the next
section) of the two states she was researching, Romania and Israel, and
the lack of regulation in the providing country. In the case of Romanian
egg provision to Israeli clinics, the Israeli Ministry of Health was a key
actor negotiating and approving the import of fertilized oocytes to Israel
in February 2002, having sent a delegation from the Ministry to inspect
the clinic in Romania set up by the Israeli physician and his Romanian-
based business partner three years earlier. In this business arrangement,
the company used the tagline: “embryos are our babies,” where a busi-
ness focus on embryos, highly skilled clinicians, techniques of oocyte
aspiration, technologies for fertilization, and an outcome of babies shift
all the attention away from the labor of the woman involved in provid-
ing the egg (Duden 1993).
Laura, twenty-two years old, a second-time donor who received
US$200 for “donating” between twenty and thirty eggs, was extractable
precisely because of the precarious labor market in Romania, where strong
trade unions were in place but the economy itself was 80 percent foreign-
owned and much employment existed in the unregulated, nonunionized
“gray market” (Nahman 2008). Laura highlights the way the uneven
development that is inherent to this fertility chain structures her
extractability:
“I don’t want to have kids now . . . . Because it’s hard to live. Raising kids is
complicated and you have to give them education. He must grow in a perfect
place. You have to offer him everything. And I cannot do this now. And I
think if somebody needs my eggs to have a baby and raise it properly I think
it’s good that I’m doing it. If I can help other people, why not?”
The amount she received equated to two months’ salary. Nevertheless,
Laura felt that it was too painful to undergo again, and yet, she added about
the egg providing, “it’s addictive, like a drug . . . it’s a constant need for
money. It’s something you need, the money. For money you can do almost
anything.” And when she heard that in the United States women may get
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paid a lot more for their eggs, Laura rightly poses her critique of the unequal
geographies of global fertility chains: “but how do I get there? It’s all about
money.”
(Post)Colonial Geographies of Uneven Development
As indicated with the example above, the third characteristic of global
fertility chains is their embeddedness in global geographies of uneven
development. Casting an economic geography perspective on the global
fertility market, Schurr (2018) argued that despite the prevalence of trans-
national flows and interconnected networks, “place continues to matter” in
these uneven geographies, referring to the importance of space, scale, ter-
ritories, localities, mobility, and borders in the reproductive bioeconomy.
Indeed, global fertility chains do not exist in a vacuum but materialize in
particular institutional, socio-spatial, and cultural environments (Coe,
Dicken, and Hess 2008).
One of the most useful insights that commodity chain analysis has gen-
erated is the differentiation between core and periphery as socio-spatial
processes of transfer of surplus value (Wallerstein 1974; Dunaway 2014).
The advantage of a chain-based approach is that it decenters Eurocentric
understandings of the global fertility industry by analyzing global reproduc-
tion networks as constituted as much by peripheral as core processes (Kelly
2009). Global fertility chains are grounded in expansive and asymmetric
geographies in which core, that is, capital- and technology-intensive pro-
cesses (such as marketing, transport, finance, and diagnostics happen in the
Global North) while peripheral, that is, labor-intensive processes (such as
gestational labor and tissue extraction) are outsourced to the “frontiers” in
the Global South and East.8 Some crucial exchanges take place in the key
areas of the periphery of the Global North. More than half of the IVF cycles
with third-party eggs in Europe, for instance, are performed in Spain
(Calhaz-Jorge et al. 2017). Furthermore, a few of the core processes take
place in countries in the Global South. Assisted reproductive services,
including IVF, intracytoplasmic sperm injection, and preimplantation
genetic diagnosis are often provided in clinics in the Global South. Many
of these local clinics, however, are currently bought up by large-scale
health-care corporations and private equity and venture capital companies
(van de Wiel 2018). An interesting example of this consolidation trend can
be found in the Spanish-born fertility corporation named The Valencian
Institute of Infertility (IVI). The IVI was created in 1990 in Valencia, one of
the early pioneers of assisted reproduction in Spain. In the past thirty years,
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IVI has set up clinics not only in several regions in Spain and across Europe
but also in North and South America, with an in-house egg bank that is able
to supply several IVI centers at the same time. In 2017, it merged with a
leading fertility corporation in the United States, Reproductive Medicine
Associates (RMA), to create the IVI-RMA, the largest reproductive medi-
cine group in the world. As we write, IVI-RMA is present in nine countries,
with more than sixty-five centers distributed all over the world that wel-
come patients traveling from more than 180 countries.9
Due to an ongoing consolidation trend in the fertility industry
through mergers, acquisitions, and joint ventures,10 much of the surplus
capital and profit actually flows back to companies based in the United
States, Australia, and Europe and their private shareholders—companies
such as Virtus Health, Care Fertility, Monash IVF Group, Medicover
Group, IVI-RMA Global, and HealthCare Global Enterprises (E. Wil-
liams, Surowiak, and Szymanski 2017; van de Wiel 2018).11 However,
these traditional postcolonial geographies of uneven development
between the Global North and South are unsettled by emerging repro-
ductive “subempires” such as India (with Nova Pulse IVF) and Abu
Dhabi (with NMC Health) as important examples (Inhorn 2015).12
There are nonetheless undeniable historical contingencies to the pro-
cesses of uneven development in the global fertility industry that relate to
both ongoing and past (settler) colonial processes of resource extraction,
conquest, slavery, and demographic settlement (Vora 2015; Vertommen
2017; Weinbaum 2019). The division of reproductive labor in the global
fertility industry is not only highly gendered but also racialized in ways that
are embedded in colonial genealogies (Deomampo 2016; Schurr 2017;
Lafuente-Funes 2017). First, there is a wide distribution gap between repro-
ductive workers across the world. A surrogate in Israel, Canada, or the
United States is paid double or almost triple the amount of surrogate in
Nepal, Mexico, Georgia, or Ukraine. This explains why most of the gesta-
tional labor is being outsourced to the Global South or East, where it forms a
cheap input for the fertility industry. Even when the purchasing power
parity (PPP) is taken into account, and the economic compensations paid
in these countries are comparably fair considering the local average salary,
the fertility sector makes significant profits selling their services at a high
price in developed countries, and little or none of this wealth is shared with
the countries where the gestational labor is carried out or where reproduc-
tive cells and gametes are harvested.
Second, there is also a racialized division of labor within different
types of reproductive services. Oocyte vendors are often recruited on the
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basis of the commissioning parents’ conceptions of “good genetic
motherhood” in terms of intelligence, physical, character, and racialized
traits, illustrative of what Schurr (2017) has called postcolonial imagin-
aries and desires of whiteness. Surrogates, however, are employed as
“mere” low-cost gestators whose genetic makeup and racialized charac-
teristics are not primordial (Twine 2011). Fieldwork conducted by Nah-
man in the fertility chain across Romania and Israel/Palestine found the
Romanian egg providers were presented by brokers as desirable primarily
for their perceived physiological similarity and “enhancement” of the
receiving population. They were presented as having a variety of eye,
skin, and hair colors to “match” the Israeli customer base. From the
perspective of recipients, the providers’ perceived “beauty”—seen as
adhering to the popular Western, Northern, and Southern European
beauty ideals of light, or light brown skin, blue/green or brown eyes,
small nose, not too large lips—was identified by recipients as their pre-
ferred feature. The clinic also built upon preexisting cultural ideals and
internalized racism among Israeli Jews (their primary client base) and a
preference for Northern or Mediterranean appearance as opposed to Arab
or African. As such, Romanian donors, viewed in part as white Eur-
opeans and in part as poor and willing donors, were seen as the perfect
match in these multiple racializing interests of recipients, brokers, and the
State, while Palestinian eggs were a taboo, demonstrating a “geography
of desirability” (Nahman 2006, 210).
Another important socio-spatial dimension of global commodity chains
is their input–output structure, which interlinks various services and prod-
ucts and sequentially adds value to the commodity as it moves through the
chain from point of extraction to the final point of consumption (Rainnie
et al. 2011). For global fertility chains, the dualism between commodity
versus “free gift” does not always uphold, as reproductive tissues often
move in and out of the commodity sphere throughout their trajectory in the
economic value chain (Waldby and Mitchell 2006; Hoeyer 2013). Kro-
løkke, Foss, and Pant (2012) describe, for instance, how oocytes have
almost no economic value upon extraction from a donor when they are
framed as a gift or as “surplus” or “waste” material from fertility clinics.
Yet, when sold as “Caucasian Ivy League eggs” by fertility agencies, or
turned into patentable stem cell lines by biotech companies, their value
increases. The mode of accumulation in the global fertility industry is a
dialectic of direct exploitation of waged labor and indirect appropriation of
unwaged labor/natures (Federici 2004; Moore 2015; Vertommen and
Barbagallo 2021)
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A final element to be taken into account in the territorial embeddedness
of global fertility chains is their variegated border and mobility regimes.
Depending on their ontological and geopolitical status, reproductive tissues,
workers, and consumers are subjected to very different mobility and migra-
tion regulations (Schurr 2018). Not everyone and everything “flows” with
the same ease throughout the chain and across national borders. While in
other care chains, such as nursing or domestic work, workers from the
Global South are employed as migrant workers in the Global North, this
is not necessarily the case for fertility chains.
For instance, when Israeli-intended parents sign a surrogacy agreement
with a Georgian surrogacy agency, the surrogate is not brought to Israel to
gestate the baby. She remains in Georgia, and once the baby is born, the
commissioning parents travel to Georgia to collect the newborn. While it is
relatively easy for frozen reproductive tissues (embryos, egg cells, or
sperm) of the commissioning parents to be shipped from Israel to Georgia,
it is more complicated for the surrogacy baby to travel across national
borders. The regulatory line between family making and child trafficking
in the surrogacy industry is thin and volatile, as various surrogacy
“scandals” in Thailand and Nepal have shown. In theory, the State of Israel
does not regulate its citizens’ use of surrogate carriers in other countries,
thus leaving the practice of transnational surrogacy in a legal liminal space.
In practice, however, the Israeli authorities have issued a series of travel and
citizenship instructions—the so-called overseas regulation—with which
commissioning parents must comply in order to regulate their parental
rights and secure the citizenship status of the surrogacy babies (Moreno
2016). Based on these prescriptions, several thousand surrogacy babies
have been granted the “right of return” as Israeli citizens, despite the appar-
ent reluctance of the state authorities.
Although in most cases surrogates and egg vendors stay in their home
country, there are exceptions in which they travel abroad as (unregulated)
migrant reproductive workers (Pande and Moll 2018). In the case of migrant
women workers who provide eggs in Spain, their migrant status as resident
but not necessarily citizen makes them ideal for being highly extractable for
the surplus value of their eggs. As Nahman writes, migrant extractability is
one instance where women actively elect to become egg providers, and their
migrant status enables them to do so on a greater number of occasions than
can be done perhaps by citizens of Spain. Their mobility enables further
opportunities for extractability. For instance, Yasmina, a woman from Ger-
many who was studying in Spain and whose sister had also been an egg
provider in Spain, stated in an interview in 2017: “In Spain, the maximum
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amount of donations is six, but I think, Leah’s [her sister] and my clinic in
particular is international and has many clinics in various countries, and
therefore one can do it more often, I think. Leah has done eight or nine
donations.”
By capitalizing both on their racial desirability to commissioning parents
and clinics as white, Western Europeans, and on their mobility around
different oocyte extracting clinics in different countries, they circumvent
any particular state law around the maximum number of times they can
provide eggs to clinics. Therefore, they maximize their ability to be extrac-
table or produce value from their bodies. In research into Israeli egg receiv-
ing from Romania, Nahman (2013) called this process, “reverse traffic,”
where European Union laws outlawing “trafficking” around human tissues
were circumvented by outsourcing the Israeli clinics themselves to another
country, and fertilizing the oocytes, since fertilized oocytes were not subject
to the same scrutiny as oocytes on their own. The model in that case was
Israeli state laws permitting egg donation, in the absence of any Romanian
laws at the time, Israeli equipment, clinicians all being transplanted to a
Romanian city, with eggs being provided by local Romanian women. After
a crisis that made its way to European courts, the Romanian state was
obliged to develop policies that both facilitated the industry and controlled
it. More recently, the more mobile migrant women, many of whom are
Eastern European and experiencing the economic drivers that take them
out of their “home” countries (“failing” economies, mass unemployment,
budget cuts, and dismantlement of welfare policies), outsource themselves
and travel to states where it is possible to make themselves extractable,
despite increased policy intervention across the European Union in the form
of European Society for Human Reproduction and Embryology and other
regulatory and guiding bodies. These examples also highlight the continued
centrality of the state in regulating global fertility chains, which brings us to
our final section.
ART of the State
Although national and supranational political institutions do not often stand
at the center of commodity and value chain research, they actually play a
crucial role in the way global fertility chains are arranged and operate.
Analytically, part of the problem is due to the role attributed to state and
supranational political institutions by the value chain scholarship on gov-
ernance. The concept of governance was originally devised by Gereffi
(1994, 97) to depict the authority and power relationships that coordinate
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the division of labor within the commodity chain and determine “how
financial, material, and human resources are allocated and flow within a
chain.” These governance mechanisms mediate the “input–output
structure” of each value chain as a sequence of value-adding economic
activities (Gereffi, Humphrey, and Sturgeon 2005; Starosta 2010; Rainnie
et al. 2011). Initially, Gereffi identified three principle types of governance
structures of global value chains: producer-driven, buyer-driven, and
Internet-driven. Later, he refined this analysis of governance mechanisms
by proposing five governance forms—market, modular, relational, captive,
and hierarchical—that were envisioned as a continuum between horizontal
coordination and vertical integration of firms (Gereffi, Humphrey, and
Sturgeon 2005). Yet, this governance analysis remained quite static and
unidimensional in understanding governance almost solely in terms of rela-
tionships of power and authority between leading firms and their immediate
suppliers rather than incorporating into the analysis other important govern-
ance stakeholders such as states, labor unions, nongovernmental organiza-
tions, households, or other actors (Rainnie et al. 2011).
Recent scholarship on bioeconomies, (late) capitalism, and neoliberal
policies has further reinforced this bias, eventually paving the way to a
fierce debate between (on one hand) those who claim that neoliberal capit-
alism strengthens and globalizes the reach and influence of markets, further
reducing the interference of the public institutions in the economy
(Biersteker 1990; Weiss 1997; Williamson 1993), and (on the other hand)
those who insist that far from having been reduced and marginalized, the
competition state is a key feature of neoliberal capitalism (Benner and
Löfgren 2007; Mazzucato 2015; Cahill and Konings 2017). As a result of
this debate, the state is increasingly recognized as an indispensable and
integral governance actor in the chain not only in its role as facilitator
(assisting firms) but also as regulator (limiting firms), producer (state-
owned firms), or buyer (state purchases output of firm; Coe, Dicken, and
Hess 2008; Yeates 2009; Horner 2017). More specifically, some scholars
have focused their attention on the issues of public procurement and direct
public investments (Benner and Löfgren 2007; Goven and Pavone 2015;
Mayer and Philips 2017). This is the case, for instance, of the health bioec-
onomy, where (publicly funded) innovation strategies and reregulation are
used to redistribute public economic resources to the private sector, reduce
citizens’ overall rights and public services to citizens, and promote new
markets (Davis and Abraham 2013; Marelli and Testa 2017; Mitra 2018).
We take these contributions seriously and put national and supranational
actors under scrutiny. Although reproductive bioeconomies are often
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presented as being managed by private actors and operating through private
markets, public institutions play a primary role in coproducing the global
fertility chain. Reproductive bioeconomies, in fact, represent just a dif-
ferent variety of state-impulsed (neoliberal) capitalism. Our focus on glo-
bal fertility chains thus allows an examination of gendered political
economy dynamics in an evergrowing world economy in which the flows
of technology, capital, patients, donors, doctors, embryos, gametes, and
norms set the background to the actual intervention of the national state to
promote and steer this economy to select political purposes. This political
project may differ from state to state, and it is important to situate the
structuring logics of the various bioeconomies in their particular socio-
historical contexts.
In the early days of cross-border egg donation, for example, the Israeli
state intervened in a clear fashion to ensure a “crisis” of a lack of eggs. The
booming IVF industry was averted by sending a Ministry of Health con-
tingent to Romania in order to ensure the smooth functioning of several
private Israeli IVF companies in their cross-border reproduction enterprise.
These companies bought human eggs at low cost from Romanian women
and sold them at a high profit margin to Israelis and other medical tourists,
while the Israeli state facilitated these reproductive bioeconomic flows in an
instance of what Nahman (2013) called “banal capitalism.” Likewise, for
Vertommen (2017), Israel’s “reproductive–industrial complex” emerged at
the crossroads of ongoing histories of biocapitalism and Zionist settler
colonialism, with its interlocking logics of capital accumulation and demo-
graphic replacement through the encouraged reproduction of the settler
population based on generous state-sponsored fertility treatments.
The Spanish case provides another interesting example. More than half
of the egg donation cycles in Europe are performed in Spain, which is also
the main exporter of eggs across Europe. A huge number of these egg
donation cycles are performed for foreign recipients, who come to Spain
for this specific reason (SEF 2020). In an interview with Pavone in 2014,
Carmen, the representative of a Spanish fertility clinic, said: “You have to
think that one of three patients here are foreigners, and indeed they look for
a donor profile we often do not have.” As a result, it is not at all strange that
some clinics do make an effort to recruit foreign donors. Nuria, a gynecol-
ogist, suggested: “Sure, there are indeed clinics who are specialized and
work mainly with foreign donors . . . it all depends on how you set the
advertisement campaign.”
In a country like Spain where the public health system is universal and
free, and where the organ donation system is entirely run by public
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institutions and reaches a degree of effectiveness and reliability unknown
elsewhere (Matesanz et al. 2017), the entire reproductive bioeconomy not
only has been dominated by private clinics and actors, including recent
commercial egg brokers and egg banks, it has also been nurtured and
protected by a technocratic approach to its regulation and a critical lack
of funding to public hospitals and social security actors (Pavone and Arias
2012; Adeces 2015). As Marta, a gynecologist, mentioned in an interview in
2015:
Q: “With the crisis [public hospitals] could not provide economic
compensation?”
A: “Yes, and also the social security system does not provide treatments to
over forties. They reduced the age limit a bit, so it is not that they do not
provide the treatment, for they do, but they have reduced it further, you
know?”
Public hospitals, however, tried to react to the lack of resources by setting
up an alternative system. Pablo, a gynecologist from a public hospital, said:
“In both public and private hospitals the conditions leading to egg donation
are the same [ . . . ]. The difference is that private centers can offer the eco-
nomic compensation established by the law, and we cannot do the same. This
means that we have an imbalance between donors and recipients [ . . . ] Wait-
ing lists were too long so we switched to crossed donation: if one patient
needs to receive eggs she has to bring in a donor, who will donate eggs to
another couple who has in the meanwhile also brought in another donor.”
Interestingly, while the donation and distribution of all human tissues
and organs are regulated and managed by the National Organization of
Transplants, the management and distribution of eggs and sperm are
(almost) entirely left to private clinics and commercial gametes banks.
Access to the reproductive bioeconomy is, thus, not only fundamentally
restricted to economically well-off individuals but is also deeply gendered,
recruiting young women into a precariously paid and uncontracted laboring
practice that effectively sustains and nurtures a burgeoning for-profit repro-
ductive economy.
As a result, the state clearly plays a constitutive role in the reproductive
bioeconomy: it operates as a key actor in enabling, regulating, and connect-
ing the local industry to the global fertility chains on which the reproductive
bioeconomy is based. In fact, the state in many countries not only has
generally contributed to the emergence of a fundamentally market-based
economy around ARTs but it also continues to maintain it in the current
neoliberal arrangements through the maintenance of multiscalar regulatory
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systems, which operate as the architecture of global fertility chains—a
selected variety of restrictive measures on access and a carefully designed
(dis)engagement.
Conclusion: Moving Forward in/with the Fertility
Chain
While a political economy framework for studying the reproductive bioec-
onomy can motivate a broad set of research questions and agendas, this
paper proposed the concept of “global fertility chains.” Our intent has been
to theorize and empirically map the global reorganization of reproductive
processes as coproduced by the changing relations—or “intra-actions”—
between capital, labor, nature/biology, and technoscience and their govern-
ance mechanisms.
As a multifaceted conceptual framework, global fertility chain analysis
proposes an integrative insight into how value is extracted and governed in
the reproductive bioeconomy and the capitalist world economy at large. The
conceptual, empirical, and political advantages of this relational framework
are manifold. First of all, it allows for the inclusion of a wide array of human
and extrahuman actors at multiple geographical scales that move beyond
the fertility company or clinic. Second, it looks at the central role of (supra)-
national state power in governing the demand and supply sides of the
fertility chain. Third, it makes visible the essential role of gendered pro-
cesses of social reproduction in the value chain and the ongoing dialectical
relation between women’s paid reproductive labor for the market and
women and nature/biology’s unpaid work for the household. Finally, it
recognizes that fertility “flows” are embedded in socio-spatial processes
of uneven development and distributed reproduction, which guarantee its
profitability.
This conceptual framework develops theoretical abstractions of the
reproductive bioeconomy and empirically grounded analyses that can in
turn (re)inform the underlying theoretical assumptions. Rather than
researching national reproductive markets, or comparing how supposedly
disparate reproductive markets operate in different countries, it looks at the
networked topography of globally intraconnected practices, operations, and
transactions through which reproductive services or commodities are pro-
duced, distributed, and consumed across the globe. This requires a metho-
dological approach that transcends the “lone researcher” model, as Coe,
Dicken, and Hess (2008) aptly framed it, and encourages a collaborative,
multisited research approach that empirically connects different (teams of)
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researchers along the fertility chain. In our case, this meant looking at the
sociotechnical and political–economic connections among reproductive
policies, practices, and markets in our respective fieldwork sites of Israel/
Palestine, Romania (egg cell provision), Georgia (surrogacy), and Spain
(egg cell provision). We would be keen to see these global fertility chains
explored in the manifold other contexts in which they exist.
Finally, as a critical value chain perspective, global fertility chain anal-
ysis is meant to identify possible sites of intervention and/or resistance
within the global network. Understanding where value is extracted, added,
and governed along the chain and how different actors are intraconnected
across borders and sectors could enable strategic interventions by unions,
civil society/grassroots organizations, and political parties, for example,
who strive for a different and more just organization of the reproductive
bioeconomy beyond capitalist regimes of exploitation and appropriation.
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Notes
1. In 2013, the director of Tammuz Family was selected in the project
“Überpreneur—36 People You Must Meet” as one of the most influential
entrepreneurs who are tackling global problems (see Andrews and Fiona Wood
2013).
2. For a critical account of the ongoing histories of (settler)colonialism and slavery
in the reproductive bioeconomy, see Weinbaum (2019), Vora (2015), and
Vertommen (2017).
3. There are important conceptual nuances and intellectual differences in the
literature on globalization and economic development between commodity
chain analysis, value chain analysis, and more recently, global production
network analysis. However, for the sake of this paper, we grouped together
these varied approaches considering they mostly share a common set of
assumptions and concerns on the global functioning of the capitalist world
economy.
4. After a surrogacy scandal with Israeli couples in Thailand in 2013, Israel’s
transnational surrogacy market moved to India. When the Indian government
prohibited commercial surrogacy for foreign couples, some Israeli surrogacy
agencies moved Indian surrogates to Nepal to give birth. After surrogacy was
banned in Nepal in 2015, a new surrogacy market was created in Cambodia and
in Laos. For now, the South East Asian surrogacy markets are closed, and
former Soviet countries are emerging as the more stable surrogacy destinations.
5. (https://evex.ge/en/; last entry February 22, 2019).
6. Fortunately, in the last decades, feminist and gendered analyses have been
increasingly incorporated into both mainstream and critical approaches to
international political economy (Dalla Costa and James 1972; Federici
2004; Bakker 2007; Steans and Tepe 2010; Mezzadri 2017; Bhattacharya
2017).
7. This argument on the “housewifization” of surrogates and egg cell providers,
who consider themselves as “mere” mothers or housewives despite their full
incorporation into capitalist markets, has been further developed in Vertommen
and Barbagallo (2021).
8. Walker and Moore (2017, 55, 59) defined the commodity frontier as “the
process of going beyond the highly capitalized zones of production to secure
sources of labour, food, energy and raw materials at below the prevailing
average cost.” According to this view, the importance of the “frontier” within
capitalism’s spatially expansive geographies is as much about seeking new
sources of cheap materials, energy, food, and workers’ bodies as it is about
new distribution markets or exporting of surplus capital.
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9. (https://www.ivirma.com; last entry September 21, 2020).
10. (https://ivi-fertility.com/notes/ivi-arrives-at-america-hand-in-hand-with-rma
nj-and-consolidates-as-the-largest-group-of-assisted-reproduction-in-the-wo
rld/; last entry August 20, 2020).
11. https://www.fertilitybridge.com/blog/2018/4/11/battleforivfmarketwallstree
tvsprivatePractice; last entry September 20, 2020).
12. Bronwyn Parry introduced the concept of reproductive (sub)empires during the
“Colonial Lineages of Global Fertility Chains” workshop (organized at King’s
College London on March 28–29, 2019) to describe how senior Indian repro-
ductive specialists are further expanding infertility service provision into emer-
ging markets such as Africa, the Middle East, and Latin America (see the
forthcoming special issue with Catalyst Journal on “Colonial Lineages of Glo-
bal Fertility Chains,” guest-edited by Sigrid Vertommen, Bronwyn Parry, and
Michal Nahman).
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respuesta a la búsqueda del hijo biológico?” Boletı́n del Ministerio de Justicia 69
(2179): 239-65.
Marelli, Lucca, and Giuseppe Testa. 2017. “Having a Structuring Effect on Europe:
The Innovative Medicines Initiative and the Construction of the European Health
Bioeconomy.” In Bioeconomies: Life, Technology and Capital in the 21st Cen-
tury, edited by Pavone Vincenzo and Johanna Goven, 71-101. Basingstoke, UK:
Palgrave Macmillan.
Marre, Diana, Beatriz San Román, and Diana Guerra. 2018. “On Reproductive
Work in Spain: Transnational Adoption, Egg Donation, Surrogacy.” Medical
Anthropology 37 (2): 158-73.
Matesanz, R., B. Domı́nguez-Gil, E. Coll, B. Mahı́llo, and R. Marazuela. . 2017.
“How Spain Reached 40 Deceased Organ Donors per Million Population.”
American Journal of Transplantation 17 (6): 1447-54.
Mayer, W. Friedrich, and Nicola Phillips. 2017. “Outsourcing Governance: States
and the Politics of a ‘Global Value Chain World’.” New Political Economy 22
(2): 134-52.
Mazzucato, Mariana. 2015. “Innovation, the State and Patient Capital.” The Polit-
ical Quarterly 86 (S1): 98-118.
Mezzadri, Alessandra. 2017. The Sweatshop Regime: Labouring Bodies, Exploita-
tion and Garments Made in India. London, UK: Cambridge University Press.
Mies, Maria. 1982. The Lace Makers of Narsapur: Indian Housewives Produce for
the World Market. London, UK: Zed Press.
Mies, Maria. 2014. Patriarchy and Accumulation of a World Scale: Women in the
International Division of Labor. London, UK: Zed Books.
Mitra, Sayani. 2018. “Cross-border Reproflows: Comparing the Cases of India,
Germany, and Israel.” In Cross-cultural Comparisons on Surrogacy and Egg
Donation: Interdisciplinary Perspectives from India, Germany and Israel, edited
by S. Mitra, S. Schicktanz, and T. Patel, 83-102. Cham, Switzerland: Springer
International.
Moore, Jason. 2015. Capitalism in the Web of Life. London, UK: Verso Books.
Moreno, Adi. 2016. “Crossing Borders Remaking Gay Fatherhood in the Global
Market.” Unpublished doctoral thesis, Department of Sociology, University of
Manchester, Manchester, UK.
Müller, Martin, and Carolin Schurr. 2016. “Assemblage Thinking and Actor-
network Theory: Conjunctions, Disjunctions, Cross-fertilisations.” Transactions
of the Institute of British Geographers 41 (3): 217-29.
Murphy, Maggy F. 2014. “Global Care Chains, Commodity Chains, and the Valua-
tion of Care: A Theoretical Discussion.” American International Journal of
Social Science 3 (5): 190-99.
30 Science, Technology, & Human Values XX(X)
Nahman, Michal. 2006. “Materializing Israeliness: Difference and Mixture in
Transnational Ova Donation.” Science as Culture 15 (3): 199-213.
Nahman, Michal. 2008. “Nodes of Desire: Romanian Egg Sellers, Dignity and
Feminist Alliances in Transnational Ova Exchanges.” European Journal of
Women’s Studies 15 (2): 65-82.
Nahman, Michal. 2013. Extractions: An Ethnography of Reproductive Tourism.
Hampshire, UK: Palgrave Macmillan.
Namberger, Verena. 2019. The Reproductive Body at Work: The South African
Bioeconomy of Egg Donation. New York: Routledge.
Newman, Susan, and Michal Nahman. 2020. “Nurture Commodified? An Investi-
gation into Commercial Human Milk Supply Chains.” Review of International
Political Economy. doi: 10.1080/09692290.2020.1864757.
Ong, Aihwa and Stephen Collier, eds. 2010. Global Assemblages: Technology,
Politics and Ethics as Anthropological Problems. Malden, MA: Blackwell.
Pande, Amrita. 2010. “Commercial Surrogacy in India: Manufacturing a Perfect
‘Mother-worker’.” Signs: Journal of Women in Culture and Society 35 (4):
969-92.
Pande, Amrita. 2014. Wombs in Labor: Transnational Commercial Surrogacy in
India. New York: Columbia University Press.
Pande, Amrita, and Tessa Moll. 2018. “Gendered Bio-responsibilities and Travel-
ling Egg Providers from South Africa.” Reproductive Biomedicine and Society
Online 6:23-33.
Parry, Bronwyn. 2018. “Surrogate Labor: Exceptional for Whom?” Economy and
Society 47 (2): 214-33.
Pavone, Vincenzo, and Flor Arias. 2012. “Beyond the Geneticization Thesis: The
Political Economy of PGD/PGS in Spain.” Science, Technology, & Human
Values 37 (3): 235-26.
Pavone, Vincenzo, and Joanna Goven. 2017. Bioeconomies: Life, Technology, and
Capital in the 21st Century. Cham, Switzerland: Palgrave Macmillan.
Ragone, Helena. 1994. Surrogate Motherhood: Conception in the Heart. Boulder,
CO: Westview Press.
Rainnie, Al, Andrew Herod, and Susan Mcgrath-Champ. 2011. “Review and Posi-
tions: Global Production Networks and Labor.” Competition and Change 15 (2):
155-69.
Rajan, Kaushik Sunder. 2006. Biocapital: The Constitution of Postgenomic Life.
Durham, NC: Duke University Press.
Rose, Nikolas. 2007. The Politics of Life Itself: Biomedicine, Power and Subjectivity
in the Twenty-first Century. Princeton, NJ: Princeton University Press.
Rudrappa, Sharmila. 2015. Discounted Life: The Price of Global Surrogacy in India.
New York: NYU Press.
Vertommen et al. 31
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